PubMed ID:
25135867
Public Release Type:
Journal
Publication Year: 2015
Affiliation: Liver Center, Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: rtchung@partners.org.
DOI:
https://doi.org/10.1016/j.jhep.2014.08.013
Authors:
Chung RT,
King LY,
Simon TG,
Zheng H
Request IDs:
7988
Studies:
The Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
Therapies that slow fibrosis progression in chronic liver disease are needed. Animal models have demonstrated that statins prevent the progression of hepatic fibrosis, but human data is lacking so far. We evaluated the association between statins and fibrosis progression in the HALT-C trial cohort.